Capital Building in Washington DC

Advocacy & Policy

To improve patient care, ASCO advocates for increased federal funding for research, greater health care access, value in cancer care, and payment reform.

  • CMS Releases Physician Fee Schedule, QPP Final Rule

    The Centers for Medicare & Medicaid Services (CMS) estimates that the overall impact of the final rule for the 2019 Medicare Physician Fee Schedule (MPFS) and Quality Payment Program (QPP) will be a 1% reimbursement cut for the hematology/oncology and radiation/oncology specialties.

    Read More
  • CMS Finalizes 2019 Cuts to Hospital Outpatient Payments and 340B
    An initial evaluation of the 2019 Hospital Outpatient Prospective Payment System final rule found that CMS is implementing provisions cutting Medicare reimbursement for certain visits to hospital outpatient clinics and extending 2018 cuts to the 340B Drug Pricing Program.
    Learn More
  • ASCO Resolutions Adopted by AMA House of Delegates

    ASCO delegates to the American Medical Association’s (AMA) House of Delegates proposed four key resolutions to advance cancer policy priorities during the interim meeting of the policy-making body held on November 10-13, 2018.

    Read More

Random Quote

"ASCO is leading the move to a new data-driven era of discovery in clinical oncology."
Peter Paul Yu, MD, FACP, FASCO
ASCO President, 2014-15